Rapacuronium Side Effects
Applies to rapacuronium: intravenous powder for injection.
Cardiovascular adverse events
Cardiovascular effects including hypotension (5.2%), tachycardia (3.2%), and bradycardia (1.5%) have been reported.[Ref]
Respiratory
Respiratory effect including bronchospasm (3.2%) have been reported.[Ref]
See also:
References
1. (2001) "Product Information. Raplon (rapacuronium)." Organon
2. Goudsouzian NG (2001) "Rapacuronium and bronchospasm." Anesthesiology, 94, p. 727-8
3. Kron SS (2001) "Severe bronchospasm and desaturation in a child associated with rapacuronium." Anesthesiology, 94, p. 923-4
4. Naguib M (2001) "How serious is the bronchospasm induced by rapacuronium?." Anesthesiology, 94, p. 924-5
5. Meakin GH, Pronske EH, Lerman J, Orr R, Joffe D, Savaree AM, Lynn AM (2001) "Bronchospasm after rapacuronium in infants and children." Anesthesiology, 94, p. 926-7
More about rapacuronium
Further information
Rapacuronium side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.